A examine released in JAMA Network Open up emphasizes the discrepancy between what it charges to generate copyright and also the retail selling prices clients encounter. Regardless of the minimal creation fees, Novo Nordisk hasn't publicly disclosed particular figures for copyright or its other product or service, Wegovy.California biotech behemoth